JC Virus in CD34+and CD19+Cells in Patients With Multiple Sclerosis Treated With Natalizumab
Abstract
Importance
Infection with JC virus (JCV) may lead to development of demyelinating progressive multifocal leukoencephalopathy in patients with multiple sclerosis (MS) who are treated with natalizumab.Objective
To determine whether mononuclear cells in circulation from MS patients treated with natalizumab harbor JCV DNA.Design, Setting, and Participants
In this prospective investigation, we enrolled 49 MS patients from...Paper Details
Title
JC Virus in CD34+and CD19+Cells in Patients With Multiple Sclerosis Treated With Natalizumab
Published Date
May 1, 2014
Journal
Volume
71
Issue
5
Pages
596 - 596
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History